Cervical Cancer Screening Using Liquid-based Cytology and its Histopathological Correlation

This is a retrospective study conducted between September 2023 and August 2024 in the Department of Obstetrics and Gynecology, Base Hospital Delhi Cantt.Data was collected from the Pap smear and cervical biopsy registers.Pap smear testing was conducted for all patients who came to the outpatient department introduction Cervical cancer is the fourth most common cancer among women worldwide.According to the World Health Organization (WHO), in 2022, there were an estimated 6,60,000 new cases, and deaths due to cervical cancer were around 3,50,000.Low-and middleincome countries have the highest incidence and mortality due to cervical carcinoma.The main factors contributing to this are the scarcity of human papillomavirus (HPV) vaccination, cervical cancer screening, and treatment facilities, as well as social and economic determinants. 1 The Global Cancer Observatory (GLOBOCAN) 2020 conducted a study to examine global variations in incidence and mortality due to cervical carcinoma, including geographical and socioeconomic development.The incidence is decreasing in most countries, and stabilizing in numerous high-income countries at relatively low levels.In contrast, during the same time period, the incidence is rising in some Eastern African and Eastern European countries. 2In India, various studies have shown that in the past 3 decades, there has been a significant reduction in the incidence and mortality due to cervical carcinoma.Singh et al. conducted a study in 2019, which showed Tamil Nadu to have the highest incidence and mortality of cervical cancer per thousand females (19.91/11.57),while Jammu and Kashmir, along with Ladakh, were found to have the lowest (6.13/3.39)incidence and mortality, respectively, during 1990 and 2019.